The CMS and FDA have been actively promoting proposed rule changes, rolling out new programs and adopting new technologies in an effort to advance the US healthcare system and modernize their agencies. From efforts to increase transparency, waivers to experiment, and adoption of Artificial Intelligence, these agencies are taking action. The team discusses some of these activities and what the impact could be to the healthcare industry.